معرفی
Professor Naomi Allen is a Professor in Epidemiology at the University of Oxford, based in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). She joined UK Biobank as Senior Epidemiologist in 2011 and became Chief Scientist in 2019, where she oversees participant follow-up through linkage with routine health-related datasets and web-based questionnaires. She plays a key role in developing the scientific strategy for future enhancements of the UK Biobank study, one of the world's largest prospective cohort studies with half a million participants.
Professor Allen's research program centers on the role of diet, obesity, and circulating biomarkers in cancer development. As co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, she leads international pooled analyses of biomarker-prostate cancer relationships. Her work spans epidemiology, oncology, metabolic disorders, and biomarker research, with particular emphasis on investigating how obesity causes cancer through metabolomics approaches.
Her recent publications demonstrate extensive utilization of the UK Biobank resource across diverse health domains. Analysis of her 15 most recent articles reveals strong focus areas in cancer biomarker discovery, metabolic syndrome and dementia risk, cardiovascular disease mechanisms, ophthalmological conditions, and innovative data linkage methodologies. The publications collectively showcase how large-scale biobank resources enable cross-disciplinary research to uncover novel disease associations and biological pathways.
Professor Allen's leadership as Chief Scientist of UK Biobank positions her at the forefront of population health research. While specific awards aren't detailed in available information, her work has garnered significant attention with multiple publications being picked up by numerous news outlets, blogged about, and widely shared across social media platforms, indicating substantial scientific impact.
Through her role at UK Biobank, Professor Allen supports thousands of researchers worldwide by maintaining and enhancing this critical resource. Her strategic vision ensures continued scientific value through innovative data collection methods, advanced analytical approaches, and strategic partnerships that maximize the study's utility for discovery and translation research across multiple disease areas.